Oct 2018 $18 M No. 14 $10 to $50 million 33
Biodesix Inc.: Raise no. 14, Oct 2018 × Investors in this round 33 investors had bought by the notice of Oct 23, 2018: 33 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $18 M of $28 M offered; $10 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bobbi Coffin · Executive Officer David Brunel · Executive Officer, Director Gary Pestano, Ph.D. · Executive Officer Heinrich Roder, D.Phil. · Executive Officer Jim Purvis · Executive Officer Linda Traylor, Ph.D. · Executive Officer Matt Stauffer · Executive Officer Paul Beresford, Ph.D. · Executive Officer Robin Cowie · Executive Officer Scott Hutton · Executive Officer Jack Schuler · Director John Patience · Director Mark Miller · Director Matthew Strobeck · Director Robert Cawthorn · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “The amount sold includes $10,511,735.63 through the issuance of stock upon the conversion of outstanding convertible securities.”Signed by Robin H. Cowie, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 23, 2018. Read the notice at the SEC .
equity SEC Jun 2018 $8 M Issued in a merger or acquisition $2 to $10 million 1
Biodesix Inc.: Private sale, Jun 2018 × Investors in this round 1 investor had bought by the notice of Jul 18, 2018: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $8 M of $8 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bobbi Coffin · Executive Officer David Brunel · Executive Officer, Director Gary Pestano, Ph.D. · Executive Officer Heinrich Roder, D.Phil · Executive Officer Jim Purvis · Executive Officer Linda Traylor, Ph.D. · Executive Officer Paul Beresford, Ph.D. · Executive Officer Robin Cowie · Executive Officer Scott Hutton · Executive Officer Jack Schuler · Director John Patience · Director Mark Miller · Director Matthew Strobeck · Director Robert Cawthorn · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Stock issued in exchange for assets. Value of stock estimated based on the original issue price of the same class and series of stock in February 2018.”Signed by Robin H. Cowie, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Jul 18, 2018. Read the notice at the SEC .
equity SEC Feb 2018 $2 M No. 13 Under $2 million 1
Biodesix Inc.: Raise no. 13, Feb 2018 × Investors in this round 1 investor had bought by the notice of Mar 9, 2018: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bobbi Coffin · Executive Officer David Brunel · Executive Officer, Director Gary Pestano, Ph.D. · Executive Officer Heinrich Roder, D.Phil. · Executive Officer Jim Purvis · Executive Officer Linda Traylor, Ph.D. · Executive Officer Paul Beresford, Ph.D. · Executive Officer Robin Cowie · Executive Officer Scott Hutton · Executive Officer Jack Schuler · Director John Patience · Director Mark Miller · Director Matthew Strobeck · Director Robert Cawthorn · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David Brunel, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 9, 2018. Read the notice at the SEC .
equity, options SEC Apr 2017 $13 M No. 12 $10 to $50 million 17
Biodesix Inc.: Raise no. 12, Apr 2017 × Investors in this round 17 investors had bought by the notice of Apr 24, 2017: 17 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $13 M of $25 M offered; $12 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bobbi Coffin · Executive Officer David Brunel · Executive Officer, Director Gary Pestano, Ph.D. · Executive Officer Heinrich Roder, D.Phil. · Executive Officer Jim Purvis · Executive Officer Linda Traylor, Ph.D. · Executive Officer Liz Fliegelman · Executive Officer Paul Beresford, Ph.D. · Executive Officer Robin Cowie · Executive Officer Wendy Blosser · Executive Officer Jack Schuler · Director John Patience · Director Mark Miller · Director Matthew Strobeck · Director Robert Cawthorn · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “The amount sold includes the conversion of outstanding convertible indebtedness.”Signed by David Brunel, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 24, 2017. Read the notice at the SEC .
equity SEC Jul 2016 $6 M No. 11 $2 to $10 million 15
Biodesix Inc.: Raise no. 11, Jul 2016 × Investors in this round 15 investors had bought by the notice of Jul 27, 2016: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $6 M of $7 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Brunel · Executive Officer, Director Robin Cowie · Executive Officer Jack Schuler · Director John Patience · Director Mark Miller · Director Matthew Strobeck · Director Robert Cawthorn · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David Brunel, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 27, 2016. Read the notice at the SEC .
equity SEC Jan 2016 $18 M No. 10 $10 to $50 million 24
Biodesix Inc.: Raise no. 10, Jan 2016 × Investors in this round 24 investors had bought by the notice of Feb 12, 2016: 24 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $18 M of $22 M offered; $4 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: Contingent value rights relating to revenue from one of Issuer's products Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Brunel · Executive Officer, Director Frank Ronchetti · Executive Officer Jack Schuler · Director John Patience · Director Mark Miller · Director Matthew Strobeck · Director Robert Cawthorn · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Offer and sale of Series F Preferred Stock, conversion of Convertible Promissory Notes and offer and sale of contingent value rights relating to revenue from one of the Issuer's products”Signed by David Brunel, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 12, 2016. Read the notice at the SEC .
equity SEC Jun 2015 $10 M No. 9 $10 to $50 million 24
Biodesix Inc.: Raise no. 9, Jun 2015 × Investors in this round 24 investors had bought by the notice of Jun 23, 2015: 24 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $10 M of $15 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Brunel · Executive Officer, Director Frank Ronchetti · Executive Officer Jack Schuler · Director John Patience · Director Mark Miller · Director Matthew Strobeck · Director Robert Cawthorn · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Frank Ronchetti, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 23, 2015. Read the notice at the SEC .
equity, options SEC Dec 2014 $11 M No. 8 $10 to $50 million 19
Biodesix Inc.: Raise no. 8, Dec 2014 × Investors in this round 19 investors had bought by the notice of Jan 13, 2015: 19 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $11 M of $18 M offered; $7 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Brunel · Executive Officer, Director Frank Ronchetti · Executive Officer Jack Schuler · Director John Patience · Director Mark Miller · Director Matthew Strobeck · Director Robert Cawthorn · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Frank Ronchetti, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 13, 2015. Read the notice at the SEC .
equity, options SEC Nov 2013 $14 M No. 7 $10 to $50 million 26
Biodesix Inc.: Raise no. 7, Nov 2013 × Investors in this round 26 investors had bought by the notice of Jan 13, 2014: 26 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $14 M of $16 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: Includes conversion of principal and interest under outstanding promissory notes. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Brunel · Executive Officer, Director Frank Ronchetti · Executive Officer Jack Schuler · Director John Patience · Director Mark Miller · Director Matthew Strobeck · Director Robert Cawthorn · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Frank Ronchetti, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Jan 13, 2014. Read the notice at the SEC .
equity SEC Oct 2013 $4 M No. 6 $2 to $10 million 21
Biodesix Inc.: Raise no. 6, Oct 2013 × Investors in this round 21 investors had bought by the notice of Oct 22, 2013: 21 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities, securities to be acquired by exercising them, other: Promissory notes convertible into equity securities of the Company. Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Brunel · Executive Officer, Director Frank Ronchetti · Executive Officer Jack Schuler · Director John Patience · Director Mark Miller · Director Matthew Strobeck · Director Robert Cawthorn · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Frank Ronchetti, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 22, 2013. Read the notice at the SEC .
options SEC Mar 2013 $7 M No. 5 $2 to $10 million 23
Biodesix Inc.: Raise no. 5, Mar 2013 × Investors in this round 23 investors had bought by the notice of Apr 11, 2013: 23 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $7 M of $15 M offered; $7 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Brunel · Executive Officer, Director Frank Ronchetti · Executive Officer Jack Schuler · Director John Patience · Director Mark Miller · Director Matthew Strobeck · Director Robert Cawthorn · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Frank Ronchetti, Chief Financial Officer. Source: SEC Form D, newest notice filed Apr 11, 2013. Read the notice at the SEC .
equity, options SEC Aug 2012 $6 M No. 4 $2 to $10 million 11
Biodesix Inc.: Raise no. 4, Aug 2012 × Investors in this round 11 investors had bought by the notice of Sep 4, 2012: 11 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $6 M of $13 M offered; $8 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Brunel · Executive Officer, Director Frank Ronchetti · Executive Officer Jack Schuler · Director John Patience · Director Mark Miller · Director Matthew Strobeck · Director Robert Cawthorn · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Frank Ronchetti, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 4, 2012. Read the notice at the SEC .
equity SEC Jun 2011 $10 M No. 3 $10 to $50 million 13
Biodesix Inc.: Raise no. 3, Jun 2011 × Investors in this round 13 investors had bought by the notice of Jul 5, 2011: 13 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $10 M of $20 M offered; $10 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Brunel · Executive Officer, Director Frank Ronchetti · Executive Officer Heinrich Roder · Executive Officer, Director Jack Schuler · Director John Patience · Director Robert Cawthorn · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Frank Ronchetti, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 5, 2011. Read the notice at the SEC .
equity SEC Oct 2010 $4 M No. 2 $2 to $10 million 16
Biodesix Inc.: Raise no. 2, Oct 2010 × Investors in this round 16 investors had bought by the notice of Oct 28, 2010: 16 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $4 M of $7 M offered; $4 M still to sell
Smallest investment taken $1
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Brunel · Executive Officer, Director Frank Ronchetti · Executive Officer Heinrich Roder · Executive Officer, Director Jack Schuler · Director John Patience · Director Robert Cawthorn · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Frank Ronchetti, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 28, 2010. Read the notice at the SEC .
equity SEC Sep 2009 $5 M No. 1 $2 to $10 million 12
Biodesix Inc.: Raise no. 1, Sep 2009 × Investors in this round 12 investors had bought by the notice of Oct 23, 2009: 12 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $5 M of $10 M offered; $5 M still to sell
Smallest investment taken $285
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Brunel · Executive Officer, Director Frank Ronchetti · Executive Officer Heinrich Roder · Executive Officer, Director Jack Schuler · Director John Patience · Director Robert Cawthorn · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Frank Ronchetti, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Oct 23, 2009. Read the notice at the SEC .
equity SEC